Repository logo

Community outbreaks of group A Streptococcus revealed by genome sequencing

Published version

Change log


Turner, C 
Bedford, L 
Brown, N 
Judge, K 
Torok, ME 


The frequent occurrence of disease outbreaks in humans caused by group A Streptococcus (GAS) is an on-going public health threat. Conventional bacterial typing methods lack the discriminatory power to confidently confirm or refute outbreaks in hospital and community settings. Microbial whole genome sequencing (WGS) provides a potential solution to this, but, there has been limited population-based surveillance with accompanying sequence data. We performed retrospective genomic surveillance of 93 clinical GAS isolates from individuals in a defined geographic region. Detailed clinical information was obtained for closely related clusters of isolates. Genomic sequence data was contextualised through comparison with international data. We identified 18 different emm genotypes within our bacterial population, and revealed both highly diverse and closely related isolates. This high level of diversity was maintained even in the context of international sequence data. We also identified two emm1 clusters, and one emm3 cluster, of closely-related isolates that differed only by 1 to 4 single nucleotide polymorphisms. Analysis of clinical information identified no healthcare associated contact between patients, indicating cryptic community transmission. Our findings suggest that genomic surveillance of GAS would increase detection of transmission and highlight opportunities for intervention.



bacterial genetics, clinical microbiology

Journal Title

Scientific Reports

Conference Name

Journal ISSN


Volume Title



Nature Publishing Group
Wellcome Trust (098600/Z/12/Z)
Academy of Medical Sciences (unknown)
Medical Research Council (MR/N029399/1)
National Institute for Health and Care Research (HICF-T5-342)
This publication presents independent research supported by the Health Innovation Challenge Fund (HICF-T5-342 and WT098600), a parallel funding partnership between the UK Department of Health and Wellcome Trust.